A5038912953- Cancer Genomics and Diagnostics
- Pancreatic and Hepatic Oncology Research
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Renal cell carcinoma treatment
- Intensive Care Unit Cognitive Disorders
- Anesthesia and Sedative Agents
- Renal and Vascular Pathologies
- Ureteral procedures and complications
- Clinical practice guidelines implementation
- Anesthesia and Neurotoxicity Research
- Neuroblastoma Research and Treatments
- Cardiac, Anesthesia and Surgical Outcomes
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Patient Safety and Medication Errors
- Diet and metabolism studies
- Lung Cancer Diagnosis and Treatment
- Trauma and Emergency Care Studies
- Radiology practices and education
- Radiomics and Machine Learning in Medical Imaging
- Minimally Invasive Surgical Techniques
- Neuroendocrine Tumor Research Advances
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Colorectal Cancer Treatments and Studies
- Abdominal Trauma and Injuries
- Lung Cancer Research Studies
Aurora St. Luke's Medical Center
2020
Jefferson Hospital
2017-2019
Abington Memorial Hospital
2017-2019
Thomas Jefferson University Hospital
2017-2018
University of Nevada, Las Vegas
2013
Various treatment options exist for patients with metastatic pancreatic neuroendocrine tumors (PNETs). Surgical resection pancreaticoduodenectomy (PD) typically reserved limited disease. Definitive data are lacking to support either the of primary PNET in setting or surgical debulking lesions.We conducted an analysis National Cancer Database (NCDB) using cancer Participant User File. Thirty- and 90-day mortality rates survival were determined undergoing PD tumor compared who had no surgery...
In the modern healthcare system, there are still wide gaps of communication imaging results to physician and patient stakeholders tracking whether follow-up has occurred. Patients also unaware significance findings in radiology reports. With increase use cross-sectional such as CT, patients not only being diagnosed with primary urgent but incidental lung nodules; however, they told their nor what actions take mitigate risks. addition, at high risk for developing cancer often obtain serial CT...
Copyright © 2016 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
Background: Solid pseudopapillary neoplasm (SPN) of the pancreas is a rare tumor which predominantly occurs in young female. This research analyzes characteristics and outcomes this disease by gender. Methods: Patients diagnosed with SPN between 1998 2012 were identified from National Cancer Data Base (NCDB) (n=389). Characteristics treatment compared genders. Results: diagnoses has continued to increase during last 15 years, majority female (324/389, 83.3%). Males are significantly later...
Sich, Nicholas; Schulingkamp, Danielle; Bertozzi, Danelle; VanHoutte, Olivier; Dehaven, Elizabeth; Kirton, Orlando; Vu, Thai; Yuschak, James; Shadis, Ryan Author Information
570 Background: Hepatobiliary cancers - hepatocellular carcinoma (HCC), intra or extrahepatic cholangiocarcinoma (I/EC), and gallbladder (GB) pancreatic adenocarcinoma (PC) do have actionable alterations (AA). The importance of testing early in a patient’s (pts) course to identify oncology precision medicine (OPM) options could be paramount for progression free survival (PFS). Methods: We identified pts with HCC, IC, EC, GB PC our OPM database since the centralization system. Pts who...
651 Background: A strengthening consensus exists for neoadjuvant therapy (NAT) in borderline resectable pancreatic adenocarcinoma (PA), but the utilization of NAT stage I PA remains controversial. Many cancer centers are using these patients (pts), others continue to offer upfront surgery and adjuvant (AT). We hypothesized that would improve margin negative resection clinical PA. Methods: utilized IRB approved 2016 national database pancreas establish a cohort pts. divided this subset into...
664 Background: We are in the midst of a paradigm shift treatment stage 1 pancreatic ductal adenocarcinoma (PDAC) from surgery first followed by adjuvant therapy (AT) to Neoadjuvant (NAT) and this is reflected current NCCN guidelines as well. Data comparing these two modalities limited. AIM: To compare long term survival between Surgery + AT NAT large National Cancer Database for PDAC. Methods: identified patients with NCDB surgically resected AJCC clinical 1, 1A, 1B PDAC 2004-2016. Patients...